Claim Missing Document
Check
Articles

Found 2 Documents
Search

Platelet Rich Plasma Injection as A Treatment for Intercostal Neuralgia: A Case Report Meliani Anggreni; Pryambodho Pryambodho; Yosi Asmara
Jurnal Sehat Indonesia (JUSINDO) Vol. 8 No. 2 (2026): Jurnal Sehat Indonesia (JUSINDO)
Publisher : CV. Publikasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59141/-.v8i2.566

Abstract

Intercostal neuralgia is a neuropathic pain condition that may persist following rib fractures, adversely affecting sleep quality and daily functioning. Conventional pharmacological and interventional treatments may provide insufficient pain relief, prompting interest in regenerative therapeutic approaches. This case report aimed to describe the clinical outcomes of ultrasound-guided perineural platelet-rich plasma (PRP) injections in a patient with refractory posttraumatic intercostal neuralgia. A 52-year-old woman presented with persistent pain along the distribution of the left tenth intercostal nerve following a rib fracture sustained 10 months earlier. Previous conservative treatment, cryoablation, and prolotherapy had failed to provide meaningful symptom relief. Autologous PRP was prepared using a double-spin centrifugation technique and administered perineurally under ultrasound guidance. Two injections were performed at a two-week interval. Pain intensity and symptom improvement were assessed using the Numeric Rating Scale (NRS) and clinical symptom evaluation. At baseline, the patient reported a pain intensity of 3–4 on the NRS, with breakthrough pain episodes reaching 6 and occurring three to five times daily, accompanied by sleep disturbances and limitations in daily activities. Following the first injection, the patient reported approximately 50% pain relief, followed by complete pain relief after the second injection. These clinical observations may be consistent with the proposed anti-inflammatory and neuroregenerative effects of PRP, although the underlying mechanisms were not directly investigated. Ultrasound-guided perineural PRP injections may represent a potential therapeutic option for refractory posttraumatic intercostal neuralgia. However, controlled clinical studies using standardized treatment protocols, objective outcome measures, and longer follow-up periods are necessary to establish their efficacy and safety.
Combined Spinal–General Anaesthesia with Low-Dose Intrathecal Morphine and Atropine for Abdominal Laparoscopy: A Randomised Controlled Trial of Postoperative Nausea, Vomiting and Pain Weirna Winantiningtyas; Muhammad Sukri Dinihar; Raden Besthadi Sukmono; Pryambodho Pryambodho
Advances In Social Humanities Research Vol. 4 No. 11 (2026): Advances In Social Humanities Research (Issue in Progres)
Publisher : Sahabat Publikasi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/adv.v4i11.722

Abstract

Postoperative nausea and vomiting (PONV) and pain remain significant concerns following abdominal laparoscopic surgery. This study compared combined spinal–general anesthesia (CSGA) incorporating low-dose intrathecal morphine and atropine with general anesthesia (GA) alone. A single-center, open-label, randomized controlled trial was conducted in Jakarta, Indonesia, from February to March 2026. Adults undergoing elective abdominal laparoscopic surgery received either CSGA with intrathecal bupivacaine (10 mg), morphine (100 ?g), and atropine (100 ?g) or GA alone. Both groups received prophylactic ondansetron and multimodal analgesia. Sixty patients were included in the per-protocol analysis, comprising 33 in the CSGA group and 27 in the GA group. The primary outcome was the incidence of PONV within 24 hours postoperatively, while secondary outcomes included pain scores, rescue medication requirements, fentanyl consumption, and hemodynamic parameters. PONV occurred in 6.1% of CSGA patients compared with 74.1% of GA patients (P < 0.001), corresponding to an absolute risk reduction of 68.0 percentage points. The CSGA group demonstrated lower pain scores at 6–24 hours, reduced postinduction fentanyl consumption, and decreased requirements for rescue ondansetron. No patients in the CSGA group required rescue morphine, compared with 59.3% in the GA group. Three CSGA patients required vasopressor support. These benefits may have been partially associated with reduced opioid exposure, although a mediating effect was not established. CSGA was associated with improved postoperative symptom control under the study conditions; however, the independent contribution of intrathecal atropine remains uncertain. Larger, blinded, multicenter randomized controlled trials are warranted to confirm efficacy and evaluate safety, particularly potential neurological complications associated with intrathecal atropine administration.